Table 2.
Baseline Clinical Characteristics, Comparing Participants With and Without a Non-HF Hospitalization.
| Variables | Non-HF hospitalization status (M ± SD or %)
|
|||
|---|---|---|---|---|
| Overall (n = 100) | No HF hospitalization (n = 86) | ≥ 1 Non-HF hospitalization (n = 14) | p value | |
| Health perception | .32 | |||
| Poor/fair | 67 (67) | 56 (65.12) | 11 (78.6) | |
| Good/very good/excellent | 33 (33) | 30 (34.9) | 3 (21.4) | |
| Provider specialty | .74 | |||
| Medicine/cardiology | 25 (25) | 21 (24.4) | 4 (28.6) | |
| HF specialist | 75 (75) | 65 (75.6) | 10 (71.4) | |
| NYHA functional class | .37 | |||
| Class I/II | 15 (15) | 14 (16.3) | 1 (7.1) | |
| Class III/IV | 85 (85) | 72 (83.7) | 13 (92.9) | |
| Ejection fraction (%) | 36.2 ± 17.5 | 36.3 ± 17.8 | 35.4 ± 16.5 | .86 |
| Low (1–2) | 24 (24) | 19 (22.1) | 5 (35.1) | |
| Medium (3–4) | 50 (50) | 45 (52.3) | 5 (35.7) | |
| High (5–11) | 26 (26) | 22 (25.6) | 4 (28.6) | |
| Medications (total number) | 11.5 ± 5.2 | 11.5 ± 5.3 | 11.5 ± 4.5 | .99 |
| Beta blocker | 84 (84) | 72 (83.7) | 12 (85.7) | .85 |
| ACE inhibitor | 33 (49.3) | 11 (42.3) | 22 (53.7) | .36 |
| ARB | 7 (10.5) | 4 (15.4) | 3 (7.3) | |
| Baseline lab values | ||||
| Hemoglobin | 11.6 ± 1.9 | 11.8 ± 2.0 | 10.4 ± 1.2 | .01 |
| Creatinine | 1.7 ± 1.2 | 1.7 ± 1.4 | 2.0 ± 2.2 | .29 |
| Comorbid conditions (total) | 5.4 ± 2.8 | 5.6 ± 2.9 | 4.5 ± 2.1 | .19 |
| Hypertension | 70 (70) | 60 (69.8) | 10 (71.4) | .90 |
| Coronary artery disease | 21 (21) | 10 (23.3) | 1 (7.1) | .17 |
| Diabetes | 50 (50) | 39 (45.4) | 11 (78.6) | .02 |
| Depression | 6 (6) | 5 (5.8) | 1 (7.1) | .85 |
| Sleep apnea | 12 (12) | 11 (12.8) | 1 (7.1) | .55 |
Note. HF = heart failure; NYHA = New York Heart Association; ACE = Angiotensin Converting Enzyme; ARB = Angiotensin II Receptor Blockers.; HMO = health maintenance organization.